First peanut allergy therapy gets backing from U.S. regulators’…

Published 7y ago

(Reuters) – A U.S. Food and Drug Administration advisory panel on Friday recommended approving the first therapy for peanut allergies, which affect over 1.6 million children in the United States, despite raising concerns about the risk of severe allergic react... More »